COX10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.724200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.214200E-01
Normal-vs-Stage2
3.379400E-01
Normal-vs-Stage3
3.296200E-02
Normal-vs-Stage4
2.324400E-01
Stage1-vs-Stage2
3.158600E-01
Stage1-vs-Stage3
4.895900E-02
Stage1-vs-Stage4
4.769600E-01
Stage2-vs-Stage3
8.894500E-02
Stage2-vs-Stage4
9.471400E-01
Stage3-vs-Stage4
7.956400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.738400E-01
Normal-vs-AfricanAmerican
6.118800E-01
Normal-vs-Asian
3.794200E-01
Caucasian-vs-AfricanAmerican
4.706800E-01
Caucasian-vs-Asian
8.651200E-01
AfricanAmerican-vs-Asian
4.584400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.500800E-01
Normal-vs-Female
3.885400E-01
Male-vs-Female
8.795600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.169400E-01
Normal-vs-Age(41-60Yrs)
6.028200E-01
Normal-vs-Age(61-80Yrs)
2.642000E-01
Normal-vs-Age(81-100Yrs)
3.010400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.934800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.879200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.890000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.094100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.176800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.642800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.318800E-01
Normal-vs-Daily Drinker
8.426100E-02
Normal-vs-Weekly Drinker
4.185800E-01
Normal-vs-Occasional Drinker
1.517180E-01
Normal-vs-Social Drinker
8.638200E-01
Non Drinker-vs-Daily Drinker
6.802000E-01
Non Drinker-vs-Weekly Drinker
4.549400E-01
Non Drinker-vs-Occasional Drinker
9.402600E-01
Non Drinker-vs-Social Drinker
1.404950E-01
Daily Drinker-vs-Weekly Drinker
2.339600E-01
Daily Drinker-vs-Occasional Drinker
7.368800E-01
Daily Drinker-vs-Social Drinker
1.238580E-01
Weekly Drinker-vs-Occasional Drinker
4.089600E-01
Weekly Drinker-vs-Social Drinker
4.936000E-01
Occasional Drinker-vs-Social Drinker
1.877840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.429600E-01
Normal-vs-Grade 2
9.184200E-01
Normal-vs-Grade 3
9.109800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.187370E-01
Grade 1-vs-Grade 3
1.975390E-01
Grade 1-vs-Grade 4
5.429600E-01
Grade 2-vs-Grade 3
8.896400E-01
Grade 2-vs-Grade 4
9.184200E-01
Grade 3-vs-Grade 4
9.109800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.526400E-01
Normal-vs-NonDiabetic
2.969800E-01
Diabetic-vs-NonDiabetic
5.291200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.191000E-01
Normal-vs-NoPancreatitis
2.823200E-01
Pancreatitis-vs-NoPancreatitis
7.593800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.597000E-01
Normal-vs-N1
2.303000E-01
N0-vs-N1
1.556350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.895700E-02
Normal-vs-TP53-NonMutant
8.927400E-01
TP53-Mutant-vs-TP53-NonMutant
7.7046000000025E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
